Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Zhengzhou 2 Wuhan 1 Changsha 1 Chengdu 1 Tianjin 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University101 First Affiliated Hospital of Zhejiang University100 AstraZeneca75 Zhejiang Cancer Hospital65 Sir Run Run Shaw Hospital44 Janssen Research & Development, LLC44 The Children's Hospital of Zhejiang University School of Medicine42 Zhejiang Provincial People's Hospital32 Hoffmann-La Roche31 Women's Hospital School Of Medicine Zhejiang University29 Sanofi24 Eli Lilly and Company24 Daiichi Sankyo18 Boehringer Ingelheim15 First People's Hospital of Hangzhou15 Novartis Pharmaceuticals14 GlaxoSmithKline13 Pfizer13 Akeso12 Takeda11 The First Affiliated Hospital of Zhejiang Chinese Medical University11 The Third Affiliated hospital of Zhejiang Chinese Medical University11 Merck Sharp & Dohme LLC10 He Huang9 The Dental Hospital of Zhejiang University School of Medicine8 AbbVie8 Gilead Sciences8 Fudan University8 Sichuan Baili Pharmaceutical Co., Ltd.8 Innovent Biologics (Suzhou) Co. Ltd.7 Alexion Pharmaceuticals, Inc.7 Suzhou Suncadia Biopharmaceuticals Co., Ltd.7 Sun Yat-sen University7 Bristol-Myers Squibb6 BioNTech SE6 Westlake University6 Bayer5 BeOne Medicines5 Abbisko Therapeutics Co, Ltd5 Astellas Pharma Global Development, Inc.5 Jichao Qin5 Betta Pharmaceuticals Co., Ltd.5 Chongqing Precision Biotech Co., Ltd5 Hangzhou DAC Biotechnology Co., Ltd.5 Jiangsu HengRui Medicine Co., Ltd.5 Xiangdong Cheng5 Zhejiang Hospital5 Guangdong Hengrui Pharmaceutical Co., Ltd5 Ruijin Hospital5 MediLink Therapeutics (Suzhou) Co., Ltd.4 Jiangsu Simcere Pharmaceutical Co., Ltd.4 Hangzhou Valgen Medtech Co., Ltd4 The Affiliated Hospital of Hangzhou Normal University4 Incyte Corporation4 Yu jiren4 Shanghai Jiaolian Drug Research and Development Co., Ltd4 UCB Biopharma SRL4 Ji Yongling4 Mao Jianhua4 Yi Liang4 Jiangsu Hansoh Pharmaceutical Co., Ltd.4 Ascentage Pharma Group Inc.4 Peking University People's Hospital3 Hangzhou Sumgen Biotech Co., Ltd.3 Shanghai Gynecologic Oncology Group3 Haisco Pharmaceutical Group Co., Ltd.3 InxMed (Shanghai) Co., Ltd.3 Shanghai Pharmaceuticals Holding Co., Ltd3 Peking University First Hospital3 Beijing InnoCare Pharma Tech Co., Ltd.3 Dizal Pharmaceuticals3 Cascade Pharmaceuticals, Inc3 Weijia Fang, MD3 Bio-Thera Solutions3 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology3 Shandong Suncadia Medicine Co., Ltd.3 Diansan Su3 Hansoh BioMedical R&D Company3 Zhejiang Provincial Tongde Hospital3 Ausper Biopharma Co., Ltd.3 Southeast University, China3 Xynomic Pharmaceuticals, Inc.3 Shanghai Henlius Biotech3 Chinese Academy of Sciences3 Multitude Therapeutics Inc.3 D3 Bio (Wuxi) Co., Ltd3 Shen Chun-Hong3 Lu Chao2 LEO Pharma2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.2 Suzhou Zelgen Biopharmaceuticals Co.,Ltd2 Li Lab,MD2 Shanghai AbelZeta Ltd.2 Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.2 Atom Therapeutics Co., Ltd2 Hangzhou Endonom Medtech Co., Ltd.2 Ding Ma2 Vivalink2 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2 Gracell Biotechnologies (Shanghai) Co., Ltd.2 Karyopharm Therapeutics Inc2 Zhejiang ACEA Pharmaceutical Co. Ltd.2 Affiliated Hospital of Nantong University2 Sinocelltech Ltd.2 Xian-Janssen Pharmaceutical Ltd.2 Shanghai Ming Ju Biotechnology Co., Ltd.2 Mabwell (Shanghai) Bioscience Co., Ltd.2 RemeGen Co., Ltd.2 SuZhou Sinus Medical Technologies Co.,Ltd2 Dexiong Han2 Tongji Hospital2 Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University2 Genzyme, a Sanofi Company2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.2 CStone Pharmaceuticals2 Beijing Tiantan Hospital2 Hangzhou Medical College2 CARsgen Therapeutics Co., Ltd.2 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 Medtronic2 OriCell Therapeutics Co., Ltd.2 The Affiliated People's Hospital of Ningbo University2 Biotheus Inc.2 Acerta Pharma BV2 Shanghai Pulmonary Hospital, Shanghai, China2 iCamuno Biotherapeutics Ltd.2 Nanjing IASO Biotechnology Co., Ltd.2 Anhui Provincial Hospital2 Innostellar Biotherapeutics Co.,Ltd2 Celgene2 Keymed Biosciences Co.Ltd2 Fuming He2 TYK Medicines, Inc2 Beijing Suncadia Pharmaceuticals Co., Ltd2 EMD Serono Research & Development Institute, Inc.2 FBD Biologics Limited2 The First Affiliated Hospital of Soochow University2 Loxo Oncology, Inc.2 Servier Bio-Innovation LLC2 Chinese PLA General Hospital2 Zheng Yabing2 Shanghai Zhongshan Hospital2 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2 Zhejiang Chinese Medical University2 Shanghai MicroPort CardioFlow Medtech Co., Ltd.2 Huabo Biopharm Co., Ltd.2 Shanghai Hengrui Pharmaceutical Co., Ltd.2 Helixon Biotechnology (Suzhou) Co., Ltd2 TransThera Sciences (Nanjing), Inc.2 Beijing Friendship Hospital2 Abbott Medical Devices2 Suzhou Sanegene Bio Inc.2 Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology2 Galderma R&D2 Qilu Pharmaceutical Co., Ltd.2 Tian'an Jiang2 InventisBio Co., Ltd2 Changchun GeneScience Pharmaceutical Co., Ltd.2 Amgen2 Jiangsu Alphamab Biopharmaceuticals Co., Ltd2 Changhai Hospital2 Genmab2 Aragon Pharmaceuticals, Inc.2 Shenyang Sunshine Pharmaceutical Co., LTD.2 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.2 Hangzhou Converd Co., Ltd.2 Shanghai Shengdi Pharmaceutical Co., Ltd1 Dimerix Bioscience Pty Ltd1 Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences1 Yang Fan, MD1 National University of Singapore1 Duk-Woo Park, MD1 Shanghai Mabgeek Biotech.Co.Ltd1 Lee's Pharmaceutical Limited1 Second Affiliated Hospital of Nanchang University1 E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.1 Zhejiang Kanova Biopharmaceutical Co., LTD1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 Shenzhen TargetRx Co., Ltd.1 Wuhan YZY Biopharma Co., Ltd.1 First Affiliated Hospital of Wenzhou Medical University1 Vifor Fresenius Medical Care Renal Pharma1 Third Affiliated Hospital, Sun Yat-Sen University1 Suzhou Genhouse Bio Co., Ltd.1 Shanghai Escugen Biotechnology Co., Ltd1 Gang Chen1 Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 Bing Xia1 Shanghai Weihe Medical Laboratory Co., Ltd.1 Suzhou Biomissile Pharmaceuticals Co., Ltd.1 Beijing Anzhen Hospital1 Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.1 Chunshui He1 Womed1 Ying Jiang1 Xiangyun Zong1 Chuanlong Zhou1 Shenzhen Core Medical Technology CO.,LTD.1 chen chao Professor1 Hangzhou Highlightll Pharmaceutical Co., Ltd1 Pengyuan Liu1 Lina Zhang1 Benethera (Shaoxing) Biotechnology Co., Ltd.1 Eikon Therapeutics1 4D Molecular Therapeutics1 Junjie Xu1 Chinese University of Hong Kong1 Genuine Seed Therapeutics (Zhuhai) Co., Ltd.1 Lingyi Biotech Co., Ltd.1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Nanjing Chia-tai Tianqing Pharmaceutical1 Chen Xiaozhong1 Yanbu Ke1 Zhuhai Fapon Biopharma Co., Ltd.1 Guizhou Sinorda Pharmaceutical Co., Ltd.1 Qian Chu1 Ranok Therapeutics (Hangzhou) Co., Ltd.1 Yi Zhou1 Kunming Pharmaceuticals, Inc.1 Bisirna Therapeutics Pte. Ltd.1 Heronova Pharmaceuticals1 SineuGene Therapeutics Co., Ltd.1 Shandong University1 Jia Fan1 Singlera Genomics Inc.1 Jiang Feng1 China National Biotec Group Company Limited1 Huashan Hospital1 Li hengjie1 Istituto Giannina Gaslini1 MedImmune LLC1 Shanghai Minwei Biotechnology Co., Ltd1 Alnylam Pharmaceuticals1 Usynova Pharmaceuticals Ltd.1 Wang Zhen1 Xie Kangjie1 Ningbo No.2 Hospital1 Hangzhou Gensciences Biopharmaceutical Co., Ltd.1 Shanghai Synvida Biotechnology Co.,Ltd.1 Qurgen Inc.1 Yanyan Liu1 Beijing Tide Pharmaceutical Co., Ltd1 Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.1 Zhejiang Hisun Pharmaceutical Co. Ltd.1 Ipsen1 Groovy Medicine (Hangzhou) Ltd.1 Xiamen University1 Beijing Chao Yang Hospital1 Wen-zhao ZHONG1 Imbioray (Hangzhou) Biomedicine Co., Ltd.1 Advenchen Laboratories, LLC1 RenJi Hospital1 Chinese SLE Treatment And Research Group1 Merz North America, Inc.1 Shanghai Longwood Biopharmaceuticals Co., Ltd.1 VelaVigo Bio Inc1 Guangdong Provincial People's Hospital1 Chen Xiangmei1 Bioray Laboratories1 Ningbo No. 1 Hospital1 Dizal (Jiangsu) Pharmaceutical Co., Ltd.1 Skyline Therapeutics1 Xiang-Qian1 Acerand Therapeutics (Hong Kong) Limited1 Singlomics Biopharmaceuticals Zhuhai Co., Ltd.1 Intra-IMMUSG Pte Ltd1 Bliss Biopharmaceutical (Hangzhou) Co., Ltd1 Guangzhou Bio-gene Technology Co., Ltd1 Chen Dajin1 Genrix (Shanghai) Biopharmaceutical Co., Ltd.1 Shanghai Vitalgen BioPharma Co., Ltd.1 Hangzhou Sciwind Biosciences Co., Ltd.1 Shanghai Mental Health Center1 Qilu Hospital of Shandong University1 Shaanxi Micot Pharmaceutical Technology Co., Ltd.1 Genentech, Inc.1 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1 Shanghai Virogin Biotech Co., Ltd.1 Acepodia Biotech, Inc.1 Wanbangde Pharmaceutical Group Co., LTD1 Tasly Pharmaceutical Group Co., Ltd1 Xiamen Amoytop Biotech Co., Ltd.1 xuexin he1 Institut de Recherches Internationales Servier1 Astellas (Beijing) Pharmaceutical R&D Co., Ltd.1 Telix Pharmaceuticals (Innovations) Pty Limited1 Simcere Pharmaceutical Co., Ltd1 Vividion Therapeutics, Inc.1 Ractigen Therapeutics.1 Otsuka Beijing Research Institute1 Shanghai Ark Biopharmaceutical Co., Ltd.1 Guangzhou Medical University1 Qiu Guoqin1 Phrontline Biopharma1 Lishu Gao1 Orphalan1 Liu Zhanghong1 The Third People's Hospital of Hangzhou1 Chaohui Yu1 Weiliang Shen, Ph.D., M.D.1 Skyline Therapeutics (US) Inc.1 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1 Debiao Kong1 Zhuhai Trinomab Pharmaceutical Co., Ltd.1 Société Internationale d'Urologie1 GeneCradle Inc1 Medtronic Cardiac Rhythm and Heart Failure1 Chaser Therapeutics, Inc.1 Yanbing Li1 Hangzhou PhecdaMed Co., Ltd.1 Bioverativ, a Sanofi company1 Ruijie Ma1 Nanfang Hospital, Southern Medical University1 Ding Ke-Feng1 Smith & Nephew, Inc.1 Lixia Sheng1 CNBG-Virogin Biotech (Shanghai) Ltd.1 Daiichi Sankyo Co., Ltd.1 Chipscreen Biosciences, Ltd.1 GrandPharma (China) Co., Ltd.1 Suzhou Immunofoco Biotechnology Co., Ltd1 Shenzhen Salubris Pharmaceuticals Co., Ltd.1 Cullgen (Shanghai),Inc1 Peking University1 Ying Yuan, MD1 Virogin Biotech Ltd.1 Shanghai IASO Biotechnology Co., Ltd1 Yifan Guo1 Jin Ying1 Lanyue Biotech (Hangzhou) Co., Ltd.1 Laekna Limited1 Wang Ping1 Beijing VDJBio Co., LTD.1 Haixing Ju, MD1 Yijun Luo1 Consun Pharmaceutical Group1 TingBo Liang1 Oneness Biotech Co., Ltd.1 Ascentawits Pharmaceuticals, Ltd1 Cell Origin Biotech (Hangzhou) Co., Ltd.1 Second Affiliated Hospital of Wenzhou Medical University1 Fujian Akeylink Biotechnology Co., Ltd.1 Newish Technology (Beijing) Co., Ltd.1 The Fourth Affiliated Hospital of Zhejiang University School of Medicine1 Yifan Wang1 Hutchmed1 Suzhou Mednovo Yi Medical Technology Co., Ltd.1 Hangzhou Weben Pharma Co., Ltd1 Shanghai Lanyi Therapeutics Co., Ltd.1 Innatus Therapeutics (Shanghai) Co., Ltd.1 Peking University Third Hospital1 Medtronic Cardiac Ablation Solutions1 Pengfei Qiu1 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.1 Chinese Academy of Medical Sciences1 BeiGene1 Minhu Chen1 Chinese Academy of Medical Sciences, Fuwai Hospital1 University of Macau1 Yinghua Xu1 Zhuhai Yufan Biotechnologies Co., Ltd1 Qian Wenbin1 Jacobio Pharmaceuticals Co., Ltd.1 Shanghai Juncell Therapeutics1 magAssist, Inc.1 Shanghai Chest Hospital1 Haihe Biopharma Co., Ltd.1 Basilea Pharmaceutica1 Suzhou Hengruihongyuan Medical Technology Co. LTD1 Ling Zhiqiang1 Hangzhou Kangji Weijing Medical Robotics Co., Ltd.1 Shenzhen Kexing Pharmaceutical Co., Ltd.1 Shanghai Hutchison Pharmaceuticals Limited1 Tianjin Medical University Cancer Institute and Hospital1 Centre Hospitalier Universitaire de Besancon1 Boston Scientific Corporation1 Shanghai BDgene Co., Ltd.1 Henan University of Traditional Chinese Medicine1 YiLin Zhao1 Taiho Oncology, Inc.1 Jiayuan Sun1 ArriVent BioPharma, Inc.1 Zai Lab (Shanghai) Co., Ltd.1 Beijing Sungen Biomedical Technology Co., Ltd1 Medtronic Cardiovascular1 Beckman Coulter, Inc.1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Latticon Antibody Therapeutics, Inc1 Kind Pharmaceuticals LLC1 Guangdong Association of Clinical Trials1 Chengdu Suncadia Medicine Co., Ltd.1 Jiangsu vcare pharmaceutical technology co., LTD1 Guangzhou Jiayin Biotech Ltd1 Hangzhou Dinova EP Technology Co., Ltd1 Zhejiang Doer Biologics Co., Ltd.1 Mirum Pharmaceuticals, Inc.1 Beijing Northland Biotech. Co., Ltd.1 Beijing Gene Key Life Technology Co., Ltd1 Wen-Ming Cao1 Genecombio Ltd.1 Peking Union Medical College Hospital1 Beijing Continent Pharmaceutical Co, Ltd.1 Wigen Biomedicine Technology (Shanghai) Co., Ltd.1 Kaili Chen1 Almazov National Medical Research Centre1 Santen Pharmaceutical Co., Ltd.1 Zhang Xiaofeng,MD1 Zhang Jianguo1 Hecheng Li M.D., Ph.D1 Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.1 LiChaoran1 Brii Biosciences Limited1 Zeng Jian1 China-Japan Friendship Hospital1 Zhejiang Yangli Pharmaceutical Technology Co., Ltd.1 Huang Haijun1 Neowise Biotechnology1 First Affiliated Hospital Xi'an Jiaotong University1 Zhejiang Haichang Biotech Co., Ltd.1 Clear sponsor filter
Site location
Zhengzhou2 Wuhan1 Changsha1 Chengdu1 Tianjin1 Hangzhou1
All 6 locations
Target enrolment
to

Trials with a site in Hangzhou

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Linperlisib Combined With Chidamide in Patients With PTCL
NCT06421948Peripheral T-cell Lymphoma
Yanyan Liu
Phase 1/2
134
Zhengzhou, Wuhan, Changsha, Chengdu, Tianjin, Hangzhou
2024-05-25
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Hangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Hangzhou?

1 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hangzhou), 1 studies
PhaseStudiesRecruitingShare
Phase 1/211100%

Most active sponsors

Lead sponsors with the most studies (Hangzhou)
Lead sponsorStudiesRecruiting
Yanyan Liu11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.